Health

Results: 901-912 of 9510

Business Wire associated0

Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany

Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease

THREE IN FOUR ALCOHOL DEATHS ARE CAUSED BY LIVER DISEASE. SCOTTISH DEATH RATE REMAINS ONE AND A HALF TIMES ENGLAND'S

Business Wire logo

Prokarium Reports Positive Interim Data from Phase 1/1b PARADIGM-1 trial of ZH9 in NMIBC patients, Demonstrating Excellent Safety and Encouraging Early Efficacy

VahatiCor CEO, Harry D. Rowland, Ph.D.

VahatiCor Appoints Harry D. Rowland, Ph.D., as Chief Executive Officer

PR Newswire associated0

LOTTE Biologics Expands Antibody Manufacturing Agreement with Ottimo Pharma

Business Wire logo

Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Selects MEVION S250-FIT™ for Southern Italy’s First Proton Therapy Center

United Imaging Unveils Its Full Radiotherapy Portfolio at ESTRO 2026, Highlighting the CE-Marked uRT-linac 506c

PR Newswire associated0

Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success

PR Newswire associated0

Recor Medical Highlights Innovation and Global Action on World Hypertension Day 2026

Business Wire logo

Organon to Present New Research on Access and Value at ISPOR 2026

Eisai projects Leqembi® revenue to total JPY 143.5 billion for fiscal year 2026 (April 2026 - March 2027)